Cavitation Technologies, Inc. (CVAT) intrinsic value & 10-year financials
Cavitation Technologies, Inc. (CVAT) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 10 fiscal years revenue shrank 21.5% a year to $203.0K, with an average return on invested capital of -110.0%.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $0.03
- Market cap
- $8.6M
- Revenue (FY2025)
- $203.0K
- Revenue growth (10-yr CAGR)
- -21.5%
- ROIC (10-yr avg)
- -110.0%
- Free cash flow (FY2025)
- —
CVAT 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $203.0K | -$113.0K | $0.00 | — | -486.2% | 38.8% |
| FY2024 | $865.0K | $439.0K | $0.00 | — | 50.6% | -69.2% |
| FY2023 | $413.0K | -$2.0M | -$0.01 | — | -214.5% | -1332.3% |
| FY2022 | $1.6M | -$619.0K | $0.00 | — | -18.5% | 84.3% |
| FY2021 | $537.0K | -$649.0K | $0.00 | -$378.0K | -139.1% | 58.1% |
| FY2020 | $1.7M | $128.0K | — | $6.0K | 8.2% | -11.1% |
| FY2019 | $1.1M | -$723.0K | — | -$296.0K | -66.3% | 49.3% |
| FY2018 | $1.3M | -$250.0K | — | $396.0K | -26.9% | 29.6% |
| FY2017 | $1.1M | -$1.1M | — | -$108.8K | -21.8% | 119.4% |
| FY2016 | $1.8M | $432.8K | — | -$821.2K | — | -67.3% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Cavitation Technologies, Inc. is facing top-line stagnation, with revenue contracting over the decade.
Cavitation Technologies, Inc. has earned high returns on invested capital, averaging 21.8% ROIC over the available history. High ROIC is consistent with a durable franchise, but it is not by itself proof of an economic moat.
Cavitation Technologies, Inc. has not shown aggressive share repurchases (>10% retirement) or a major balance-sheet leverage increase (>50% net debt growth) over the 10-year window.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, Cavitation Technologies, Inc. is modeled at -21.5% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-0.02 per share.